Skip to end of metadata
Go to start of metadata

Combinatorial high-throughput screenings of RNAi with compounds have the power to experimentally identify compound-protein interactions and can help to unravel the underlying mechanisms of the development of resistance and the sensitization to compound treatment. This screening approach can be implemented in various ways and has the potential to evaluate the selectivity of known drugs and to modify candidates toward higher selectivity.

  • No labels